Education
About Us
Working with TipRanks
Follow Us
Easton Pharmaceuticals Inc (EAPH)
OTHER OTC:EAPH
| Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | $ 0.00 | $ 1.56M | $ 378.59K |
| Gross Profit | $ 0.00 | $ 201.40K | $ 106.91K |
| Operating Income | $ -189.00K | $ -322.00K | $ -124.00K |
| EBITDA | $ -8.33K | $ -6.59K | $ -124.00K |
| Net Income | $ -189.00K | $ -323.00K | $ -169.00K |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ 23.19B | $ 247.97K | $ 66.30K |
| Total Assets | $ 10.19M | $ 17.17M | $ 10.15M |
| Total Debt | $ 2.48M | $ 8.46M | $ 2.18M |
| Net Debt | $ 2.48M | $ 8.21M | $ 2.11M |
| Total Liabilities | $ 3.28M | $ 10.08M | $ 3.01M |
| Stockholders' Equity | $ 6.91M | $ 7.10M | $ 7.14M |
| Cash Flow | |||
| Free Cash Flow | $ -207.34K | $ 491.88K | $ -6.86K |
| Operating Cash Flow | $ -188.54K | $ 510.68K | $ -6.86K |
| Investing Cash Flow | $ -18.80K | $ -18.80K | $ 0.00 |
| Financing Cash Flow | $ 64.00 | $ 1.12K | $ 18.37K |
Easton Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.